[1] MOL BWJ, ROBERTS CT, THANGARATINAM S, et al. Pre-eclampsia. Lancet. 2016;387(10022):999-1011.
[2] WEBSTER K, FISHBURN S, MARESH M, et al. Diagnosis and management of hypertension in pregnancy: summary of updated NICE guidance. BMJ. 2019;366:l5119.
[3] CHAIWORAPONGSA T, CHAEMSAITHONG P, YEO L, et al. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014;10(8):466-480.
[4] KUMASAWA K. Animal Models in Preeclampsia. Preeclampsia. 2018: 141-155.
[5] KOLOVETSIOU-KREINER V, MOERTL MG, PAPOUSEK I, et al. Maternal cardiovascular and endothelial function from first trimester to postpartum. PLoS One. 2018;13(5):e0197748.
[6] BAIJNATH S, SOOBRYAN N, MACKRAJ I, et al. The optimization of a chronic nitric oxide synthase (NOS) inhibition model of pre-eclampsia by evaluating physiological changes. Eur J Obstet Gynecol Reprod Biol. 2014;182:71-75.
[7] ZHU H, ZHU W, HU R, et al. The effect of pre-eclampsia-like syndrome induced by L-NAME on learning and memory and hippocampal glucocorticoid receptor expression: A rat model. Hypertens Pregnancy. 2017;36(1):36-43.
[8] LIU W, QIAO F, LIU H, et al. Low molecular weight heparin improves proteinuria in rats with L-NAME induced preeclampsia by decreasing the expression of nephrin, but not podocin. Hypertens Pregnancy. 2015;34(1):24-35.
[9] IJOMONE OK, SHALLIE PD, NAICKER T. Nꭃ-nitro-l-arginine methyl model of pre-eclampsia elicits differential IBA1 and EAAT1 expressions in brain. J Chem Neuroanat. 2019;100:101660.
[10] ALONSO-VENTURA V, LI Y, PASUPULETI V, et al. Effects of preeclampsia and eclampsia on maternal metabolic and biochemical outcomes in later life: a systematic review and meta-analysis. Metabolism. 2020; 102:154012.
[11] SIA WW, PERTMAN SM, YAN RM, et al. Are Preeclampsia and Adverse Obstetrical Outcomes Predictors of Cardiovascular Disease? A Case-Control Study of Women With Heart Disease. J Obstet Gynaecol Can. 2019;41(12):1760-1767.
[12] HEIDEMA WM, SCHOLTEN RR, VAN DRONGELEN J, et al. Metabolic Syndrome After Preeclamptic Pregnancy: A Longitudinal Cohort Study. J Womens Health (Larchmt). 2019;28(3):357-362.
[13] WIEGMAN MJ, ZEEMAN GG, AUKES AM, et al. Regional distribution of cerebral white matter lesions years after preeclampsia and eclampsia. Obstet Gynecol. 2014;123(4):790-795.
[14] 吴牧熙,沈桂权,高波.先兆子痫对脑结构和功能影响的研究进展[J].磁共振成像,2019,10(12):924-927.
[15] FIELDS JA, GAROVIC VD, MIELKE MM, et al. Preeclampsia and cognitive impairment later in life. Am J Obstet Gynecol. 2017;217(1):74.e1-74.e11.
[16] IJOMONE OK, SHALLIE P, NAICKER T. Changes in the structure and function of the brain years after Pre-eclampsia. Ageing Res Rev. 2018; 47:49-54.
[17] BASIT S, WOHLFAHRT J, BOYD HA. Pre-eclampsia and risk of dementia later in life: nationwide cohort study. BMJ. 2018;363:k4109.
[18] 张阳,杨慧,杨柳,等.二甲双胍在妊娠期高血压疾病中的研究现状和前景展望[J].中华妇产科杂志,2020,55(8):567-571.
[19] IJOMONE OK, SHALLIE PD, NAICKER T. Oligodendrocytes Death Induced Sensorimotor and Cognitive Deficit in N-nitro-L-arginine methyl Rat Model of Pre-eclampsia. Neurochem Res. 2020;45(4):902-914.
[20] HU J, ZHANG J, ZHU B. Protective effect of metformin on a rat model of lipopolysaccharide-induced preeclampsia. Fundam Clin Pharmacol. 2019;33(6):649-658.
[21] ZHANG X, LI Q, JIANG W, et al. LAMA5 promotes human umbilical vein endothelial cells migration, proliferation, and angiogenesis and is decreased in preeclampsia. J Matern Fetal Neonatal Med. 2020;33(7): 1114-1124.
[22] MARTINEZ-FIERRO ML, HERNADEZ-DELGADILLO GP, FLORES-MENDOZA JF, et al. Fibroblast Growth Factor Type 2 (FGF2) Administration Attenuated the Clinical Manifestations of Preeclampsia in a Murine Model Induced by L-NAME. Front Pharmacol. 2021;12:663044.
[23] POSSOMATO-VIEIRA JS, KHALIL RA. Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia. Adv Pharmacol. 2016;77:361-431.
[24] NEMA J , SUNDRANI D , JOSHI S . Prenatal vitamin D supplementation reduces blood pressure and improves placental angiogenesis in an animal model of preeclampsia. Food Funct. 2020;11(12):10413-10422.
[25] NAVARATNAM K, ABREU P, CLARKE H, et al. Evaluation of agreement of placental growth factor (PlGF) tests and the soluble FMS-like tyrosine kinase 1 (sFlt-1)/PlGF ratio, comparison of predictive accuracy for pre-eclampsia, and relation to uterine artery Doppler and response to aspirin. J Matern Fetal Neonatal Med. 2019;32(2):179-187.
[26] BENSCHOP L, SCHALEKAMP-TIMMERMANS S, BROERE-BROWN ZA, et al. Placental Growth Factor as an Indicator of Maternal Cardiovascular Risk After Pregnancy. Circulation. 2019;139(14):1698-1709.
[27] POON LC, GALINDO A, SURBEK D, et al. From first-trimester screening to risk stratification of evolving pre-eclampsia in second and third trimesters of pregnancy: comprehensive approach. Ultrasound Obstet Gynecol. 2020;55(1):5-12.
[28] CHEN J, KHALIL RA. Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia. Prog Mol Biol Transl Sci. 2017;148:87-165.
[29] MARKOVIC S, ROUSSEL T, NEEMAN M, et al. Deuterium Magnetic Resonance Imaging and the Discrimination of Fetoplacental Metabolism in Normal and L-NAME-Induced Preeclamptic Mice. Metabolites. 2021;11(6):376.
[30] COATES BJ, BRODERICK TL, BATIA LM, et al. MgSO4 prevents left ventricular dysfunction in an animal model of preeclampsia. Am J Obstet Gynecol. 2006;195(5):1398-1403.
[31] ROBERTS TJ, CHAPMAN AC, CIPOLLA MJ. PPAR-gamma agonist rosiglitazone reverses increased cerebral venous hydraulic conductivity during hypertension. Am J Physiol Heart Circ Physiol. 2009;297(4): H1347-1353.
[32] YANG X, GUO L, SUN X, et al. Protective effects of hydrogen-rich saline in preeclampsia rat model. Placenta. 2011;32(9):681-686.
[33] LI Y, YANG N, WANG B, et al. Effect and mechanism of prophylactic use of tadalafil during pregnancy on l-NAME-induced preeclampsia-like rats. Placenta. 2020;99:35-44.
[34] ZHANG Y, LIU X, YANG L, et al. Current Researches, Rationale, Plausibility, and Evidence Gaps on Metformin for the Management of Hypertensive Disorders of Pregnancy. Front Pharmacol. 2020;11: 596145.
[35] SONG WY, DING H, DUNN T, et al. Low-dose metformin treatment in the subacute phase improves the locomotor function of a mouse model of spinal cord injury. Neural Regen Res. 2021;16(11):2234-2242.
[36] PONIEDZIAŁEK-CZAJKOWSKA E, MIERZYŃSKI R, DŁUSKI D, et al. Prevention of Hypertensive Disorders of Pregnancy-Is There a Place for Metformin? J Clin Med. 2021;10(13):2805.
[37] LIU T, HONG L, YANG Y, et al. Metformin reduces proteinuria in spontaneously hypertensive rats by activating the HIF-2α-VEGF-A pathway. Eur J Pharmacol. 2021;891:173731.
[38] DENG-BRYANT Y, LEUNG LY, CAUDLE K, et al. Cognitive Evaluation Using Morris Water Maze in Neurotrauma. Methods Mol Biol. 2016; 1462:539-551.
[39] WHITING MD, KOKIKO-COCHRAN ON. Assessment of Cognitive Function in the Water Maze Task: Maximizing Data Collection and Analysis in Animal Models of Brain Injury. Methods Mol Biol. 2016; 1462:553-571.
[40] WANG HL, LIU FL, LI RQ, et al. Electroacupuncture improves learning and memory functions in a rat cerebral ischemia/reperfusion injury model through PI3K/Akt signaling pathway activation. Neural Regen Res. 2021;16(6):1011-1016.
[41] LIU X, ZHAO W, LIU H, et al. Developmental and Functional Brain Impairment in Offspring from Preeclampsia-Like Rats. Mol Neurobiol. 2016;53(2):1009-1019.
[42] KUCUK M, UGUR YILMAZ C, ORHAN N, et al. The Effects of Lipopolysaccharide on the Disrupted Blood-Brain Barrier in a Rat Model of Preeclampsia. J Stroke Cerebrovasc Dis. 2018;27(12):3411-3418.
[43] YANG X, DING Y, YANG M, et al. Nestin Improves Preeclampsia-Like Symptoms by Inhibiting Activity of Cyclin-Dependent Kinase 5. Kidney Blood Press Res. 2018;43(2):616-627.
|